<tei>
    <teiHeader>
        <fileDesc xml:id="_5js4h5rlkxxr-en.pdf"/>
    </teiHeader>
    <text xml:lang="en">


        <figure type="table">

            <head>TABLE </head>
 
            <label>OF </label>
 
            <head>CONTENTS</head>
        </figure>


        <figure type="table">

            <figDesc>The share of hospital care costs in total health spending is falling, but still accounts for 29% of<lb/> expenditure in OECD countries<lb/> 10.<lb/> The following brief overview of hospital spending seeks to put the use of DRG-based payment<lb/> and payment reductions based on a tapering scale in OECD countries into a financial context.<lb/> </figDesc>
<lb/> 
            <table>11.<lb/> Spending on hospital care accounted, on average, for 2.6% of gross domestic product (GDP) in<lb/> OECD countries in 2011 (OECD Health Statistics, 2013) but differed widely across countries. The figure<lb/> was highest for France (4.2% of GDP), followed by Austria (3.6%) and Greece (3.4% of GDP). At the<lb/> other end of the scale, Chile devoted only 1% of its GDP to inpatient care.<lb/> 12.<lb/> In a similar way, per capita spending on hospital care ranged from USD PPP 209 to 1 660 in<lb/> 2011. It stood at USD PPP 1 482 in France which was about 50% above the OECD average of<lb/> USD PPP 973 (</table>
        </figure>


        <figure type="table">

            <table>* Inpatient curative and follow-up care and rehabilitation, including one-day stays.<lb/> ** Includes domiciliary care and ancillary services.<lb/> 1 In the USA, fees charged by independent doctors for inpatients are included in outpatient care.<lb/> Source: OECD Health Statistics 2013.<lb/> 14.<lb/> Spending on inpatient care (including day care in hospitals) is the biggest cost component for a<lb/> number of countries, including France and Greece where it accounts for 37% of total spending –<lb/> 8 percentage points more than the average for the OECD countries.<lb/> 15.<lb/> On average, spending on inpatient care in OECD countries continued to grow in 2010 and 2011,<lb/> albeit at a markedly slower rate than in 2008 and 2009 (</table>
        </figure>


        <figure type="table">

            <table>37 36 35 32 32 32 31 31 30 30 30 30 29 29 29 29 28 28 27 27 26 26 25 25 22 20 18<lb/> 22<lb/> 27 28 28<lb/> 28<lb/> 33 35 34 36<lb/> 26 26<lb/> 36<lb/> 22<lb/> 30 33 31 33<lb/> 42<lb/> 34 35<lb/> 45 48<lb/> 38<lb/> 28<lb/> 33<lb/> 33 35<lb/> 51<lb/> 11 1<lb/> 15<lb/> 6<lb/> 9<lb/> 9<lb/> 4<lb/> 15<lb/> 4 21<lb/> 29 10<lb/> 24 12<lb/> 12 19<lb/> 24 8<lb/> 20 21 2<lb/> 8<lb/> 11<lb/> 4<lb/> 12<lb/> 0<lb/> 15<lb/> 6<lb/> 21 31<lb/> 17<lb/> 26 24<lb/> 22 24<lb/> 11 24<lb/> 17<lb/> 11<lb/> 17 15 20<lb/> 20<lb/> 18<lb/> 11<lb/> 16 11 12<lb/> 23<lb/> 15<lb/> 21<lb/> 37<lb/> 23<lb/> 38<lb/> 20<lb/> 14<lb/> 9<lb/> 4<lb/> 5<lb/> 4<lb/> 7<lb/> 5<lb/> 6 10<lb/> 5<lb/> 6<lb/> 3<lb/> 7<lb/> 9<lb/> 9<lb/> 6<lb/> 4<lb/> 3<lb/> 6<lb/> 7<lb/> 5<lb/> 4<lb/> 3<lb/> 5<lb/> 6<lb/> 7<lb/> 6 10 11<lb/> 0<lb/> 10<lb/> 20<lb/> 30<lb/> 40<lb/> 50<lb/> 60<lb/> 70<lb/> 80<lb/> 90<lb/> 100<lb/> %<lb/> Inpatient care*<lb/> Outpatient care**<lb/> Long-term care<lb/> Medical goods<lb/> Collective services Figure 3: Average annual growth rates of health spending for selected functions, in real terms, OECD average,<lb/> 2008 to 2011<lb/> Source: OECD Health Statistics 2013</table>
        </figure>


        <figure type="table">

            <table>4.8%<lb/> 5.9%<lb/> 2.9%<lb/> 6.9%<lb/> 2.5%<lb/> 3.2%<lb/> 4.6%<lb/> 6.2%<lb/> 2.8%<lb/> 6.4%<lb/> 3.5%<lb/> 0.7%<lb/> 0.9%<lb/> 5.3%<lb/> 0.2%<lb/> -1.5%<lb/> -0.9%<lb/> 1.0%<lb/> 1.7%<lb/> 1.6%<lb/> -1.7%<lb/> -1.7%<lb/> 1.7%<lb/> -3%<lb/> -2%<lb/> -1%<lb/> 0%<lb/> 1%<lb/> 2%<lb/> 3%<lb/> 4%<lb/> 5%<lb/> 6%<lb/> 7%<lb/> 8%<lb/> Inpatient care Outpatient care Long-term care Pharmaceuticals<lb/> Prevention<lb/> Administration<lb/> 2007/08<lb/> 2008/09<lb/> 2009/10<lb/> 2010/11</table>
        </figure>


        <figure type="table">

            <head>Table</head>

            <label>1</label>

            <head>: Basic health care coverage in the OECD countries<lb/> Main source of basic health care cover<lb/> Countries<lb/> </head>
<lb/> 
            <table>Tax-funded system of health care<lb/> Australia, Canada, Denmark, Finland, Hungary,<lb/> Iceland, Ireland, Italy, New Zealand, Norway, Portugal,<lb/> Spain, Sweden, United Kingdom<lb/> Health insurance<lb/> system<lb/> Single payer<lb/> Korea, Luxembourg, Poland, Slovenia, Turkey,<lb/> Greece*<lb/> Multiple insurers with<lb/> automatic affiliation<lb/> Austria, Belgium, France, Japan, Mexico<lb/> Multiple insurers with free<lb/> choice of insurer<lb/> Chile, Czech Republic, Germany, Israel, Netherlands,<lb/> Slovakia, Switzerland, USA<lb/> * As of 2012<lb/> Source: OECD Health System Characteristics Survey 2012<lb/> 18.</table>
        </figure>


        <figure type="table">

            <table>0%<lb/> 10%<lb/> 20%<lb/> 30%<lb/> 40%<lb/> 50%<lb/> 60%<lb/> 70%<lb/> 80%<lb/> 90%<lb/> 100%<lb/> Gen Govt<lb/> Social Security<lb/> Private Health Insurance<lb/> Private OOP<lb/> Rest Figure 5: Structure of public and private hospital funding in 2011 (or nearest year)<lb/> Note: No data for the other OECD countries.<lb/> Source: OECD Health Statistics 2013.</table>
        </figure>


        <figure type="table">

            <head>table </head>
 
            <label>below</label>

            <head>)</head>

            <figDesc>. Adjustments can be applied to DRG tariffs to allow, for example, for specific factors such as hospital<lb/> location, hospital status or patient characteristics.</figDesc>
        </figure>


        <figure type="table">

            <head>Table</head>

            <label>: </label>
 
            <head>DRG weight approach<lb/> </head>
<lb/> 
            <table>Source: adapted from Busse (2011)</table>
        </figure>


        <figure type="table">

            <head>table</head>

            <label>.<lb/> </label>
<lb/> 
            <table>DRG weight<lb/> Monetary<lb/> conversion*<lb/> Adjustment<lb/> Hospital payment<lb/> tariff<lb/> Relative weights<lb/> 1.95<lb/> EUR 2000<lb/> EUR 3900<lb/> Raw tariff<lb/> EUR 3000<lb/> 1.3<lb/> EUR 3900<lb/> * may be set for each individual hospital 22.<lb/> Most countries with health insurance systems (14 out of 20 countries) have the same main<lb/> method of hospital payment regardless of a hospital&apos;s legal status (</table>
        </figure>


        <figure type="table">

            <head>Table </head>
 
            <label>2</label>

            <head>: Main hospital payment method used by health insurance systems, by legal status of hospitals, in<lb/> 2012<lb/> </head>
<lb/> 
            <table>Public hospital<lb/> Private not-for-profit<lb/> hospital<lb/> Private for-profit<lb/> hospital<lb/> Austria<lb/> DRG-based<lb/> DRG-based<lb/> DRG-based<lb/> Belgium<lb/> Global budget<lb/> Global budget<lb/> n.a.<lb/> Chile<lb/> DRG-based<lb/> DRG-based<lb/> Line-item remuneration<lb/> Czech Republic<lb/> DRG-based<lb/> DRG-based<lb/> DRG-based<lb/> Estonia<lb/> DRG-based<lb/> France<lb/> DRG-based<lb/> DRG-based<lb/> DRG-based<lb/> Germany<lb/> DRG-based<lb/> DRG-based<lb/> DRG-based<lb/> Greece<lb/> DRG-based<lb/> DRG-based<lb/> Fee-for-service<lb/> Hungary<lb/> DRG-based<lb/> DRG-based<lb/> Fee-for-service<lb/> Israel<lb/> Fee-for-service<lb/> Fee-for-service<lb/> Fee-for-service<lb/> Japan<lb/> DRG-based<lb/> DRG-based<lb/> n.a.<lb/> Korea<lb/> Fee-for-service<lb/> Fee-for-service<lb/> n.a.<lb/> Luxembourg<lb/> Global budget<lb/> Global budget<lb/> n.a.<lb/> Mexico<lb/> Global budget<lb/> Fee-for-service<lb/> Fee-for-service<lb/> Netherlands<lb/> DRG-based<lb/> DRG-based<lb/> n.a.<lb/> Poland<lb/> DRG-based<lb/> DRG-based<lb/> DRG-based<lb/> Slovakia<lb/> Fee-for-service<lb/> Fee-for-service<lb/> Fee-for-service<lb/> Slovenia<lb/> DRG-based<lb/> DRG-based<lb/> DRG-based<lb/> Switzerland<lb/> DRG-based<lb/> DRG-based<lb/> DRG-based<lb/> USA (Medicare)<lb/> DRG-based<lb/> DRG-based<lb/> Fee-for-service 23.<lb/> Tax-funded national health systems tend to pay hospitals using a prospective global budget<lb/> (</table>
        </figure>


        <figure type="table">

            <head>Table </head>
 
            <label>3</label>

            <head>: Main method used to pay hospitals, by legal status, in 2012 in systems funded by taxation<lb/> </head>
<lb/> 
            <table>Public hospital<lb/> Private not-for-profit<lb/> hospital<lb/> Private for-profit<lb/> hospital<lb/> Australia<lb/> DRG-based<lb/> Fee-for-service<lb/> Fee-for-service<lb/> Canada<lb/> Global budget<lb/> Global budget<lb/> Global budget<lb/> Denmark<lb/> Global budget<lb/> n.a.<lb/> DRG-based<lb/> Finland<lb/> DRG-based<lb/> Iceland<lb/> Global budget<lb/> n.a.<lb/> n.a.<lb/> Ireland<lb/> Global budget<lb/> Global budget<lb/> Italy<lb/> Global budget<lb/> DRG-based<lb/> DRG-based<lb/> New Zealand<lb/> Global budget<lb/> n.a.<lb/> n.a.<lb/> Norway<lb/> Global budget<lb/> Global budget<lb/> DRG<lb/> Portugal<lb/> Global budget<lb/> Fee-for-service<lb/> Fee-for-service<lb/> Spain<lb/> Line item remuneration<lb/> Global budget<lb/> Sweden<lb/> Global budget<lb/> Global budget<lb/> Global budget<lb/> United Kingdom<lb/> DRG-based<lb/> Fee-for-service<lb/> Fee-for-service 25.<lb/> The increasing use of DRG-based payments serves as a financial incentive to hospitals to reduce<lb/> costs per patient and average length of stay thus improving technical efficiency. But payment via DRG also<lb/> encourages hospitals to</table>
        </figure>


        <figure type="table">

            <head>Table </head>
 
            <label>4</label>

            <head>: The different procedures analysed in the Health Benefit Basket project<lb/> </head>
<lb/> 
            <table>Treatment<lb/> Patient characteristics<lb/> Location where carried<lb/> out<lb/> Case type 1<lb/> Appendectomy<lb/> Male, 14 to 25 years<lb/> Inpatient care<lb/> Case type 2<lb/> Normal childbirth<lb/> Female, 25 to 34 years<lb/> Inpatient care<lb/> Case type 3<lb/> Hip replacement<lb/> Female, 65 to 75 years<lb/> Inpatient care<lb/> Case type 4<lb/> Stroke<lb/> Male, 60 to 70 years<lb/> Inpatient care<lb/> Case type 5<lb/> Acute myocardial<lb/> infarction<lb/> Male, 50 to 60 years<lb/> Inpatient care<lb/> Source: Busse et al. (2007).</table>
        </figure>


        <figure type="table">

            <head>Table </head>
 
            <label>5</label>

            <head>: Description of data used when evaluating economies of scale in the hospital sector and cost elasticity<lb/> </head>
<lb/> 
            <table>Date<lb/> Authors<lb/> Country<lb/> Data<lb/> Types of data<lb/> Number of hospitals<lb/> Cost<lb/> elasticity<lb/> 1983<lb/> Cowing<lb/> et al.<lb/> USA<lb/> Administrative data from New York State<lb/> Cross-sectional data<lb/> 1975<lb/> 138 general hospitals<lb/> 0.86<lb/> 1990<lb/> Vita<lb/> USA<lb/> California Health Facilities Survey (1983)<lb/> Cross-sectional data<lb/> 1983<lb/> 296 general hospitals<lb/> 1.26<lb/> 1997<lb/> Menke<lb/> USA<lb/> Annual survey of American Hospital Association<lb/> Bureau of the Census (salary data)<lb/> Guide to Hospital Performance (HCIA) for quality indicators<lb/> The Area Resource File (ARF) for information on the region<lb/> in which hospital is established<lb/> Cross-sectional data<lb/> 1990<lb/> 2 200 hospitals<lb/> Not<lb/> quantified<lb/> 2006<lb/> Smet<lb/> Belgium<lb/> Administrative data from the Belgian Federal Public Service<lb/> of Health, Food Chain Safety and Environment<lb/> Cross-sectional data<lb/> 1997<lb/> 187 general hospitals<lb/> 1.15<lb/> 2000<lb/> Carey<lb/> USA<lb/> Annual survey of American Hospital Association<lb/> Data from Healthcare Financing Administration, based on<lb/> Hospital Cost Reporting Information System<lb/> Panel data<lb/> 1987-1991<lb/> 1 733 hospitals<lb/> 0.68<lb/> 2001<lb/> Li et al.<lb/> USA<lb/> Administrative data from Washington State (Health<lb/> Department)<lb/> Panel data<lb/> 1988 to 1993<lb/> 910 hospitals<lb/> 0.62<lb/> 2008<lb/> Cohen<lb/> et al.<lb/> USA<lb/> Administrative data from Washington State (Health<lb/> Department)<lb/> Panel data<lb/> 1997 to 2002<lb/> 93 hospitals<lb/> 0.68<lb/> 2010<lb/> Cohen<lb/> et al.<lb/> USA<lb/> Administrative data from the State of Connecticut<lb/> (Department of Public Health)<lb/> Panel data<lb/> 2006 to 2008<lb/> 30 hospitals<lb/> 2.27<lb/> 2011<lb/> Cohen and<lb/> Paul<lb/> USA<lb/> Administrative data from Washington State (Health<lb/> Department)<lb/> Panel data<lb/> 1997 to 2004<lb/> 17 hospitals<lb/> 0.75</table>
        </figure>


        <figure type="table">

            <head>Table</head>
        </figure>


        <figure type="table">

            <table>Actual Case-Mix<lb/> Change in<lb/> Case-Mix<lb/> Growth<lb/> rate of<lb/> Case-mix<lb/> Negotiated<lb/> federal<lb/> base rate<lb/> (EUR)<lb/> Rate of<lb/> growth in<lb/> federal<lb/> base rate<lb/> MLA<lb/> 2004<lb/> 15 476 804<lb/> 2005<lb/> 16 033 965<lb/> 557 161<lb/> 3.60%<lb/> 2006<lb/> 16 528 236<lb/> 494 271<lb/> 3.10%<lb/> 2007<lb/> 17 148 731<lb/> 620 495<lb/> 3.80%<lb/> 2008<lb/> 17 683 593<lb/> 534 862<lb/> 3.10%<lb/> 2009<lb/> 18 084 944<lb/> 401 351<lb/> 2.30%<lb/> Negotiated rate<lb/> 2010<lb/> 18 559 432<lb/> 474 488<lb/> 2.60%<lb/> 2935.78<lb/> 2011<lb/> 18 764 079<lb/> 204 647<lb/> 1.10%<lb/> 2963.82<lb/> 1.00% Rate set at 30%<lb/> 2012<lb/> 19 101 878<lb/> 337 799<lb/> 1.80%<lb/> 2991.53<lb/> 0.90% Negotiated rate<lb/> 2013<lb/> 3068.37<lb/> 2.60% Rate set at 25%<lb/> 2014<lb/> 3156.82<lb/> 2.90%<lb/> Rate set at 25%<lb/> with 2012 as<lb/> benchmark<lb/> volume 79.<lb/> Schreyögg et</table>
        </figure>


        <figure type="table">

            <head>Hospitals<lb/> 86.<lb/> In 2009, hospital expenditure<lb/> 17 in Maryland matched that for the United States (37% and 36%<lb/> respectively), accounting for 5.5% of gross domestic product in the State of Maryland and the United<lb/> States.</head>
        </figure>


        <figure type="table">

            <figDesc>per<lb/> 1,000 Population<lb/> United States<lb/> Maryland<lb/> No tapering payment insurers and hospitals. Thanks to this, Maryland has been able to implement innovative tariff policies in<lb/> hospitals.</figDesc>
        </figure>


        <figure type="table">

            <table>136.<lb/> Hospital expenditure in Israel accounted for 1.9% of GDP in 2009, lower than the OECD average<lb/> (2.6% of GDP). 137.<lb/> On average, </table>
 
            <head>59% of expenditure on hospital services is funded by social security (the four<lb/> insurers), 33% by the State, 5% by corporations and 2% directly by households. These out-of-pocket<lb/> expenditures are not co-payments since acute hospital services are free at the point of delivery; they<lb/> include payments for services which are not included in the basic health care basket.<lb/> </head>
<lb/> 
            <table>138.<lb/> One of the features of hospital provision in Israel is the low number of beds. There are 3.3 beds<lb/> per 1 000 population, ranking Israel 19 th among OECD countries for this indicator. The average number of<lb/> beds in OECD countries is 4.9 per 1 000 population. The number of beds remained stable between 2000<lb/> and 2011 in Israel (+0.5%)</table>
        </figure>


        <figure type="table">

            <head>Table </head>
 
            <label>7</label>

            <head>: The tapering payment mechanism in Israel<lb/> Remuneration of activities above the Gross<lb/> Revenue Cap<lb/> Remuneration of activities if the Gross Revenue<lb/> Cap is not reached<lb/> </head>
<lb/> 
            <table>Cap reached<lb/> All activities paid with<lb/> agreed discounts = Net<lb/> Revenue Cap<lb/> If activities are less<lb/> than 95% of the cap<lb/> Guaranteed income of 95% of<lb/> the Net Revenue Cap<lb/> Overshoot of 0-2%<lb/> 70% of the negotiated<lb/> price<lb/> Activity of between<lb/> 95% and 100% of the<lb/> Gross Revenue Cap<lb/> Payment of 95% of the Net<lb/> Revenue Cap<lb/> +<lb/> 30% for undelivered activities<lb/> between 95% and 100% of the<lb/> Gross Revenue Cap<lb/> Overshoot of the cap by<lb/> between 2% and 13%<lb/> 33% of the negotiated<lb/> price<lb/> Overshoot of the cap by more<lb/> than 13%<lb/> 65% of the negotiated<lb/> price</table>
        </figure>


        <figure type="table">

            <head>Table </head>
 
            <label>8</label>

            <head>: Summary<lb/> </head>
<lb/> 
            <table>Czech Republic<lb/> Germany<lb/> Israel<lb/> Maryland<lb/> Hospital payment methods in 2013 or 2014<lb/> Hospital<lb/> payment<lb/> method<lb/> DRGs since 2009<lb/> (except in 2011).<lb/> DRGs since 2003 (80%<lb/> of hospital revenue).<lb/> Fee-for-service,<lb/> procedure-based<lb/> payments, per diem<lb/> payments.<lb/> Global budget and<lb/> DRGs (7% of hospitals<lb/> in 2014).<lb/> DRG-based<lb/> tariffs<lb/> Each hospital applies a<lb/> single DRG-based tariff<lb/> to all insurers.<lb/> Differences between<lb/> hospitals until 2014<lb/> intended to smooth<lb/> the transition to DRG-<lb/>based payment and<lb/> tariffs were expected<lb/> to convergence.</table>
        </figure>


        <figure type="table">

            <table>when<lb/> tapering was<lb/> introduced<lb/> 2009, but a global<lb/> budget applied to<lb/> hospitals in 2011 and<lb/> 2014.<lb/> 1985 (before the<lb/> introduction of DRGs).<lb/> Second level of<lb/> tapering introduced in<lb/> 2009.<lb/> 1994 (introduction of<lb/> universal health<lb/> insurance), several<lb/> changes in parameters<lb/> since then.<lb/> 1977, withdrawn<lb/> between 2001 and<lb/> 2008, then<lb/> reintroduced.<lb/> Aims of<lb/> tapering<lb/> To prevent inflationary<lb/> effects during the shift<lb/> to DRG-based<lb/> payment. The<lb/> economic crisis and the<lb/> need to control growth<lb/> in expenditure led to<lb/> the system remaining<lb/> in use.<lb/> To contain hospital<lb/> spending growth and<lb/> volume increase;<lb/> justified by existence of<lb/> economies of scale in<lb/> hospital production.<lb/> To constrain growth in<lb/> the use of hospital<lb/> services and reduce<lb/> insurers&apos; expenditure<lb/> on services above a<lb/> given cap.<lb/> The rationale behind<lb/> the introduction of the<lb/> variable cost factor<lb/> (VCF) was to take into<lb/> account economies of<lb/> scale.<lb/> Areas where<lb/> tapering<lb/> applies<lb/> Almost all activities are<lb/> subject to tapering<lb/> payment. There may<lb/> be exceptions, but<lb/> these arise out of<lb/> bilateral agreements<lb/> between insurers and<lb/> hospitals, the details of<lb/> which are not readily<lb/> available.<lb/> All DRG-based<lb/> payments. Activities<lb/> excluded: transplants,<lb/> equipment-intensive<lb/> DRGs (2/3 of costs);<lb/> reduced tapering for<lb/> severely injured<lb/> All hospital activities.<lb/> All activities but<lb/> adjustments may be<lb/> made to allow for the<lb/> impact which new<lb/> activities will have.<lb/> Definition of<lb/> tapering<lb/> The Ministry of Health<lb/> draws up the formula<lb/> to be used to calculate<lb/> Principles laid down at<lb/> federal level (two<lb/> thresholds and two<lb/> Parameters (thresholds<lb/> and scales) laid down<lb/> by the Government for<lb/> Principles laid down by<lb/> the independent<lb/> government agency Czech Republic<lb/> Germany<lb/> Israel<lb/> Maryland<lb/> parameters<lb/> the cap above which<lb/> tapering applies.<lb/> rates of tapering).<lb/> &quot; Negotiated &quot; activity<lb/> thresholds for each<lb/> hospital based on past<lb/> performance and<lb/> projected activity.<lb/> Tapering scales laid<lb/> down nationally (this<lb/> has changed over<lb/> time).<lb/> three years.<lb/> Hospitals and insurers<lb/> sign individual<lb/> contracts and<lb/> negotiate further<lb/> discounts and<lb/> adjustments in<lb/> tapering parameters in<lb/> 90% of cases.<lb/> responsible for<lb/> managing hospital<lb/> charges (HSCRC, Health<lb/> Services Cost Review<lb/> Commission).<lb/> Tapering scale laid<lb/> down for all state<lb/> hospitals.<lb/> Threshold<lb/> above which<lb/> tapering<lb/> applies</table>
        </figure>


        <figure type="table">

            <table>Tapering<lb/> scales<lb/> 50%.<lb/> First tapered scale:<lb/> 25% in 2013.<lb/> Second tapered scale:<lb/> 65%.<lb/> Scale 1 (applies<lb/> between 100% and<lb/> 102% of the threshold):<lb/> 30%.<lb/> Scale 2 (between 102%<lb/> and 113% of the<lb/> threshold): 67%.<lb/> Scale 3 (above 113% of<lb/> the threshold): 35%.<lb/> 50% in the 1980s,<lb/> 15% in the 1990s,<lb/> 50% currently.<lb/> Benchmark<lb/> year and<lb/> adjustments<lb/> The trends accounted<lb/> for in the method of<lb/> calculating the cap are<lb/> calculated using year t<lb/> and year t-2.<lb/> Generally speaking, the<lb/> activity actually<lb/> performed in the<lb/> previous year acts as a<lb/> benchmark. In 2014,<lb/> the benchmark year is<lb/> 2012.<lb/> In 2014, the<lb/> benchmark year was<lb/> 2012 to avoid<lb/> incorporating a sharp<lb/> increase in activity that<lb/> occurred in 2013.</table>
        </figure>


        <figure type="table">

            <table>an increase in activity<lb/> above the threshold.<lb/> Application<lb/> of tapering<lb/> in practice<lb/> Following year<lb/> (between April and<lb/> June).<lb/> Adjustment of tariffs in<lb/> the current year.<lb/> Adjustment of tariffs in<lb/> the current year.<lb/> Current year with the<lb/> option to make<lb/> corrections the<lb/> following year.<lb/> Hospital<lb/> protection<lb/> mechanisms<lb/> The hospital is<lb/> remunerated at a rate<lb/> of 20% for all activity<lb/> that is &quot; negotiated &quot;<lb/> but not performed.<lb/> Guaranteed income for<lb/> the hospital: full<lb/> remuneration for 95%<lb/> of the negotiated<lb/> activity, plus payment<lb/> of 30% of the price for<lb/> services not performed<lb/> in the range of 95%-<lb/>100% of the activity<lb/> cap &quot; &quot; negotiated &quot; .<lb/> Where activity is lower<lb/> than the revenue<lb/> authorised, the<lb/> hospital receives<lb/> payment for the share<lb/> of the fixed costs<lb/> incorporated in the<lb/> income that it should<lb/> have received in t.<lb/> Impact of tapering<lb/> Changes in<lb/> activity<lb/> The Ministry of Health<lb/> reported a slight fall in<lb/> case mix in 2012 but<lb/> did not link it to<lb/> tapering.<lb/> Lower rate of growth in<lb/> case mix since 2009,<lb/> but difficult to relate<lb/> this to the introduction<lb/> of the second level of<lb/> tapering.<lb/> Significant increase in<lb/> inpatient admissions,<lb/> outpatient<lb/> consultations and<lb/> operating costs<lb/> following the removal<lb/> of tapering between<lb/> 2001 and 2008<lb/> (Kalman, 2014).<lb/> Savings due<lb/> to tariff<lb/> reductions<lb/> Not known.<lb/> Expected savings in<lb/> 2011-12 EUR 270-<lb/>350 million (0.5% of<lb/> hospital costs).<lb/> On average, 10% of all<lb/> payments to hospitals<lb/> if national parameters<lb/> are applied, plus 7% in<lb/> reductions secured<lb/> through negotiation.<lb/> Not known.<lb/> Impact on<lb/> waiting<lb/> times,<lb/> quality of<lb/> care<lb/> No evidence.<lb/> Unknown<lb/> No evidence.<lb/> No evidence.</table>
        </figure>


        <figure type="table">

            <head>Table </head>
 
            <label>A</label>

            <head>.1: History and main characteristics of hospital stay classification systems introduced in selected<lb/> OECD countries<lb/> </head>
<lb/> 
            <table>Date<lb/> introduced<lb/> Classification<lb/> system<lb/> Number of groups<lb/> Revision<lb/> Germany<lb/> 2003<lb/> G-DRG 2012<lb/> 1 193<lb/> Annually<lb/> Austria<lb/> 1997<lb/> Katalog<lb/> medizinischer<lb/> Einzelleistungen<lb/> (MEL) for<lb/> procedures<lb/> 1 004<lb/> Marginal adjustment<lb/> annually and full revision<lb/> every 7 years<lb/> USA (Medicare)<lb/> 1983<lb/> MSDRGs<lb/> ~2 400<lb/> Annually<lb/> France<lb/> 2005<lb/> GHM<lb/> ~2 500<lb/> Annually<lb/> Netherlands<lb/> 2005<lb/> DBC<lb/> ~30 000<lb/> Sporadically<lb/> Czech Rep.<lb/> 2009<lb/> Adjusted IR DRG<lb/> 1 046<lb/> Annually<lb/> Slovenia<lb/> 2003<lb/> ICD-10-AM (AR-<lb/>DRG V 4.2)<lb/> 653<lb/> Minor amendments<lb/> annually<lb/> Switzerland<lb/> 2012<lb/> SwissDRG 1.0<lb/> 991<lb/> Annually<lb/> Australia<lb/> 2003 and<lb/> nationwide as<lb/> of 2012<lb/> AR-DRG<lb/> Classification<lb/> (Version 6.0)<lb/> 698<lb/> Every one to 2 years<lb/> Chile<lb/> 2003<lb/> Valued benefit<lb/> program<lb/> n.a.<lb/> Annually<lb/> Denmark<lb/> 2004<lb/> DKDRG 2012<lb/> 717<lb/> Annually<lb/> Finland<lb/> 1997<lb/> NordDRG<lb/> 500 inpatient, ~900<lb/> including outpatients<lb/> Annually<lb/> United Kingdom 2003 partially<lb/> HRG v4<lb/> ~1 200<lb/> Annually<lb/> Italy<lb/> 1995<lb/> DRG 24 v<lb/> 538<lb/> Every 3 years<lb/> Norway<lb/> 1997<lb/> NordDRG<lb/> 870<lb/> Annually<lb/> Portugal<lb/> 1984<lb/> AP-DRG v21<lb/> 669<lb/> Sporadically<lb/> Sweden<lb/> 1995<lb/> NordDRG<lb/> 983 (in and outpatient,<lb/> day cases)<lb/> Annually<lb/> Note: The Netherlands is currently reforming its payment system and associated classification (KCE, 2013).<lb/> Source: OECD Health System Characteristics Survey, 2012.<lb/> </table>
<lb/> 
            <figDesc>175.<lb/> The USA was the first country to introduce a DRG-based classification for its hospitals as part of<lb/> its Medicare programme (for patients aged 65 and over). Use of this patient classification system grew and<lb/> accelerated in OECD countries during the 2000s as information technology became more sophisticated.<lb/> Thirteen OECD countries adopted this system during the 2000s out of the 21 which now use it and for<lb/> which figures are available. 176.<lb/> Three types of OECD countries can be distinguished by the way in which they went about<lb/> adopting DRG-based payment systems (</figDesc>
        </figure>


        <figure type="table">

            <table>Austria<lb/> DRG-based payment<lb/> DRG-based payment<lb/> DRG-based payment<lb/> No<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Chile<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Line-item remuneration<lb/> No<lb/> No<lb/> No<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Czech<lb/> Republic<lb/> Block budget<lb/> Block budget<lb/> Block budget<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Estonia<lb/> DRG-based payment<lb/> n.a.<lb/> n.a.<lb/> Yes<lb/> --<lb/>--<lb/>Yes<lb/> --<lb/>--<lb/>France<lb/> DRG-based payment<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Germany<lb/> DRG-based payment<lb/> DRG-based payment<lb/> DRG-based payment<lb/> No<lb/> No<lb/> No<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Greece<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Fee-for-service payment<lb/> No<lb/> No<lb/> Yes<lb/> No<lb/> No<lb/> No<lb/> Hungary<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Fee-for-service payment<lb/> No<lb/> No<lb/> Yes<lb/> No<lb/> No<lb/> No<lb/> Israel<lb/> Fee-for-service payment<lb/> Fee-for-service payment<lb/> Fee-for-service payment<lb/> No<lb/> No<lb/> No<lb/> No<lb/> No<lb/> No<lb/> Korea<lb/> Fee-for-service payment<lb/> Fee-for-service payment<lb/> n.a.<lb/> Yes<lb/> Yes<lb/> --<lb/>No<lb/> No<lb/> --<lb/>Luxembourg<lb/> Block budget<lb/> Block budget<lb/> n.a.<lb/> No<lb/> No<lb/> --<lb/>Yes<lb/> Yes<lb/> --<lb/>Netherlands<lb/> DRG-based payment<lb/> DRG-based payment<lb/> n.a.<lb/> Yes<lb/> Yes<lb/> --<lb/>Yes<lb/> Yes<lb/> --<lb/>Poland<lb/> DRG-based payment<lb/> DRG-based payment<lb/> DRG-based payment<lb/> No<lb/> No<lb/> No<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Slovenia<lb/> DRG-based payment<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Yes<lb/> Yes<lb/> --<lb/>Yes<lb/> Yes<lb/> --<lb/>Switzerland<lb/> DRG-based payment<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> USA<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Fee-for-service payment<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> No<lb/> Yes<lb/> Australia<lb/> DRG-based payment<lb/> Fee-for-service payment<lb/> Fee-for-service payment<lb/> No<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Denmark<lb/> Block budget<lb/> n.a.<lb/> DRG-based payment<lb/> Yes<lb/> --<lb/>Yes<lb/> No<lb/> --<lb/>No<lb/> Finland<lb/> DRG-based payment<lb/> Yes<lb/> --<lb/>--<lb/>Yes<lb/> --<lb/>--<lb/>Italy<lb/> Block budget<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> No<lb/> Norway<lb/> Block budget<lb/> Block budget<lb/> DRG-based payment<lb/> Yes<lb/> Yes<lb/> No<lb/> No<lb/> No<lb/> No<lb/> United<lb/> Kingdom<lb/> DRG-based payment<lb/> Fee-for-service payment<lb/> Fee-for-service payment<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Hospital payments<lb/> Capital costs taken into account<lb/> Teaching and training taken into<lb/> account separately Table A.3: Scope of DRG-based payment for certain health services in the OECD countries<lb/> Source: OECD Health System Characteristics Survey 2012.<lb/> Public hospital<lb/> Not-for-profit private hospital<lb/> For-profit private hospital<lb/> Austria<lb/> DRG-based payment<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Yes<lb/> Belgium<lb/> Block budget<lb/> Block budget<lb/> n.a.<lb/> No<lb/> No<lb/> No<lb/> No<lb/> Chile<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Line-item remuneration<lb/> No<lb/> In some cases<lb/> Yes<lb/> In some cases<lb/> Czech Republic<lb/> Block budget<lb/> Block budget<lb/> Block budget<lb/> Yes<lb/> Yes, usually<lb/> Yes, usually<lb/> Yes<lb/> France<lb/> DRG-based payment<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Yes for those requiring a stay in<lb/> hospital<lb/> No<lb/> No<lb/> Public hospital: Yes<lb/> Private hospital: No<lb/> Germany<lb/> DRG-based payment<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Yes<lb/> In part<lb/> In part<lb/> Specialist not hospital-based but<lb/> authorised to practise in a<lb/> hospital: No<lb/> Locums: Yes<lb/> Greece<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Fee-for-service payment<lb/> Yes<lb/> Yes, usually<lb/> Yes, usually<lb/> Public hospital: n.a.<lb/> Private hospital: No<lb/> Hungary<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Fee-for-service payment<lb/> Yes<lb/> No<lb/> No<lb/> Yes<lb/> Japan<lb/> DRG-based payment<lb/> DRG-based payment<lb/> n.a.<lb/> No<lb/> In part<lb/> In part<lb/> Yes<lb/> Netherlands<lb/> DRG-based payment<lb/> DRG-based payment<lb/> n.a.<lb/> Yes<lb/> In part<lb/> No<lb/> Yes<lb/> Poland<lb/> DRG-based payment<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Yes<lb/> Yes<lb/> Yes, but cost of use only,<lb/> not purchase cost<lb/> Yes<lb/> Slovenia<lb/> DRG-based payment<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Usually: part of the care provided in<lb/> day care hospitals is paid for out of a<lb/> global budget<lb/> No<lb/> Yes<lb/> Yes<lb/> Switzerland<lb/> DRG-based payment<lb/> DRG-based payment<lb/> DRG-based payment<lb/> No<lb/> Yes<lb/> Yes, with exceptions<lb/> Yes<lb/> USA<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Fee-for-service payment<lb/> No<lb/> Yes<lb/> Yes<lb/> No<lb/> Australia<lb/> DRG-based payment<lb/> Fee-for-service payment<lb/> Fee-for-service payment<lb/> No<lb/> Yes<lb/> Yes<lb/> Public patient: Yes<lb/> Private patient: No<lb/> Denmark<lb/> Block budget<lb/> n.a.<lb/> DRG-based payment<lb/> Yes<lb/> Yes<lb/> Yes<lb/> -<lb/>Finland<lb/> DRG-based payment<lb/> Yes<lb/> Yes<lb/> Yes<lb/> -<lb/>Italy<lb/> Block budget<lb/> DRG-based payment<lb/> DRG-based payment<lb/> Yes<lb/> Yes, but most regions<lb/> authorise additional<lb/> payments for a range of<lb/> anti-cancer drugs<lb/> Yes, but some regions<lb/> authorise additional<lb/> payments for a regional list<lb/> of medical devices<lb/> Yes<lb/> Norway<lb/> Block budget<lb/> Block budget<lb/> DRG-based payment<lb/> Yes<lb/> In some cases<lb/> -<lb/>No<lb/> Portugal<lb/> Block budget<lb/> Fee-for-service payment<lb/> Fee-for-service payment<lb/> -<lb/>In part<lb/> -<lb/>Yes<lb/> Sweden<lb/> Block budget<lb/> Block budget<lb/> Block budget<lb/> Yes<lb/> Some excluded by some<lb/> regions<lb/> Some excluded by some<lb/> regions<lb/> -<lb/>United Kingdom<lb/> DRG-based payment<lb/> Fee-for-service payment<lb/> Fee-for-service payment<lb/> Yes<lb/> In part<lb/> In part<lb/> Hospital payments<lb/> Day care included<lb/> Expensive drugs included<lb/> Expensive medical devices<lb/> included<lb/> Payments to private doctors<lb/> included ANNEX 2: SETTING THE POINT VALUE IN GERMANY<lb/> DELSA/HEA/WD/HWP(2015)1<lb/> 71<lb/> Période t<lb/> F<lb/> E<lb/> D<lb/> E<lb/> R<lb/> A<lb/> L<lb/> L<lb/> A<lb/> N<lb/> D<lb/> E<lb/> R<lb/> Insurers&apos;<lb/> representative<lb/> Hospitals<lb/> representative<lb/> Federal<lb/> point<lb/> value<lb/> Negociation<lb/> Période t+1<lb/> +2.5%<lb/> -1.25%<lb/> Land<lb/> point<lb/> value<lb/> Maximum rate of growth in Land<lb/> point value<lb/> Federal<lb/> point value<lb/> Point value band for<lb/> the Land<lb/> Hospital cost index rate<lb/> Wage index rate<lb/> Federal<lb/> point<lb/> value<lb/> Growth of wages<lb/> + (1/3 (hospital<lb/> cost index-growth<lb/> of wages))</table>
        </figure>


        <figure type="table">

            <table>(CM 2013 ) α × (1.05 × N 2013 × (CM 2011 /N 2011 )) (1-α) = CM 2013</table>
        </figure>


        <figure type="table">

            <head>CAP REV 2013 = max {min [1.07 × CM red × ITC 2011 ; CM red × TC 2013 ]; CM red × ITC 2011 }<lb/> First, let us explain min [1.07 × CM red × ITC 2011 ; CM red × TC 2013 ]</head>
        </figure>


        <figure type="table">

            <head>(</head>

            <label>2015</label>

            <head>)<lb/> DEMENTIA RESEARCH AND CARE: CAN BIG DATA HELP? (2015)<lb/> FIT MIND, FIT JOB – FROM EVIDENCE TO PRACTICE IN MENTAL HEALTH AND WORK (2015)<lb/> MAKING MENTAL HEALTH COUNT: THE SOCIAL AND ECONOMIC COSTS OF NEGLECTING<lb/> MENTAL HEALTH CARE (2014)<lb/> HEALTH AT A GLANCE: EUROPE (2014)<lb/> HEALTH AT A GLANCE: ASIA/PACIFIC (2014)<lb/> OECD HEALTH STATISTICS 2014 (Database available from http://www.oecd.org/health/healthdata<lb/> GEOGRAPHIC VARIATIONS IN HEALTH CARE: WHAT DO WE KNOW AND WHAT CAN BE DONE<lb/> TO IMPROVE HEALTH SYSTEM PERFORMANCE? (2014)<lb/> PAYING FOR PERFORMANCE IN HEALTH CARE: IMPLICATIONS FOR HEALTH SYSTEM<lb/> PERFORMANCE AND ACCOUNTABILITY (2014)<lb/> OBESITY HEALTH UPDATE (2014) http://www.oecd.org/els/health-systems/Obesity-Update-2014.pdf<lb/> (electronic format only)<lb/> OECD REVIEWS OF HEALTH CARE QUALITY – CZECH REPUBLIC (2014)<lb/> OECD REVIEWS OF HEALTH CARE QUALITY – DENMARK (2013)<lb/> OECD REVIEWS OF HEALTH CARE QUALITY – ITALY (2015)<lb/> OECD REVIEWS OF HEALTH CARE QUALITY – NORWAY (2014)<lb/> OECD REVIEWS OF HEALTH CARE QUALITY – SWEDEN (2013)<lb/> OECD REVIEWS OF HEALTH CARE QUALITY – TURKEY (2014)<lb/> CANCER CARE – ASSURING QUALITY TO IMPROVE SURVIVAL (2013)<lb/> ICTs AND THE HEALTH SECTOR –TOWARDS SMARTER HEALTH AND WELLNESS MODELS (2013)<lb/> A GOOD LIFE IN OLD AGE? MONITORING AND IMPROVING QUALITY IN LONG-TERM CARE<lb/> (2013)<lb/> STRENGTHENING HEALTH INFORMATION INFRASTRUCTURE FOR HEALTH CARE QUALITY<lb/> GOVERNANCE (2013)<lb/> WAITING TIME POLICIES IN THE HEALTH SECTOR, WHAT WORKS? (2013)<lb/> </head>
<lb/> 
            <table>HEALTH AT A GLANCE (2013): OECD INDICATORS (2013)<lb/> See http://www.oecd.org/health/healthataglance for more information<lb/> HEALTH AT A GLANCE (2013): OECD INDICATORS (2013)<lb/> See http://www.oecd.org/health/healthataglance for more information</table>
        </figure>



    </text>
</tei>

